Lista de obras - Ray L. Watts - Dominio Público Uruguay

A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease

artículo científico publicado en 2007

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study

artículo científico publicado en 2003

A long-term study of istradefylline in subjects with fluctuating Parkinson's disease

artículo científico publicado en 2010

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

artículo científico

Absence of previously reported variants in theSCNA (G88C and G209A),NR4A2 (T291D and T245G) and theDJ-1 (T497C) genes in familial Parkinson's disease from theGenePD study

article

Activation of subthalamic neurons by contralateral subthalamic deep brain stimulation in Parkinson disease ⬇️

artículo científico publicado el 22 de diciembre de 2010

Age at onset in two common neurodegenerative diseases is genetically controlled

artículo científico publicado en 2002

An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines

artículo científico publicado en 2001

Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists ⬇️

artículo científico publicado el 1 de julio de 2003

Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease

artículo científico publicado en 2001

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease

artículo científico publicado en 2003

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

article

Benefits and Risks of Pharmacological Treatments for Essential Tremor

artículo científico publicado el 1 de enero de 2003

Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year

artículo científico publicado en 2009

Brain N-acetylaspartate is reduced in Parkinson disease with dementia

artículo científico publicado en 2008

Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia

artículo científico publicado en 2008

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

artículo científico publicado en 2006

Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid.

artículo científico publicado en 1991

Clozapine is beneficial for psychosis in Parkinson's disease

scientific article published on 01 October 1991

Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PD.

artículo científico publicado en 2011

Complete genomic screen in Parkinson disease: evidence for multiple genes.

artículo científico publicado en 2001

Complications of Gamma Knife Surgery for Parkinson Disease

scientific article published on 01 December 2001

Construction of relational topographies from the quantitative measurements of functional deep brain stimulation using a 'roving window' interpolation algorithm

artículo científico publicado en 2009

Corticobasal degeneration

artículo científico publicado en 2007

Corticobasal degeneration: neuropathologic and clinical heterogeneity

artículo científico publicado en 1997

Depression associated with Parkinson's disease: clinical features and treatment

artículo científico publicado en 2002

Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease

artículo científico publicado en 2004

Early Experience with Autologous Intrastriatal Adrenal Medulla/Nerve Cografting in Parkinson's Disease

artículo científico publicado en 1992

Effect of Stereotaxic Intrastriatal Cografts of Autologous Adrenal Medulla and Peripheral Nerve in Parkinson's Disease: Two-Year Follow-up Study ⬇️

artículo científico publicado el 1 de octubre de 1997

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

artículo científico publicado en 2002

Effects of deep brain stimulation frequency on bradykinesia of Parkinson's disease

artículo científico publicado en 2014

Electrophysiologic analysis of early Parkinson's disease

scientific article published on 01 August 1991

Electrophysiologic analysis of early Parkinson's disease

artículo científico publicado en 1991

Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study.

artículo científico publicado en 2002

Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial

artículo científico publicado en 2015

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease

artículo científico publicado en 2003

Genome-wide scan for Parkinson's disease: the GenePD Study

artículo científico publicado en 2001

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

artículo científico publicado en 2003

Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.

artículo científico publicado en 2007

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study

artículo científico publicado en 2008

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study

article

High-frequency deep brain stimulation of the putamen improves bradykinesia in Parkinson's disease

artículo científico publicado en 2011

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study

artículo científico publicado en 2008

Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementia.

artículo científico publicado en 2013

Implantation of Spheramine in advanced Parkinson's disease (PD).

artículo científico publicado en 2004

Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study

artículo científico publicado en 2006

Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease

artículo científico publicado en 2005

Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia.

artículo científico publicado en 2008

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

artículo científico publicado en 2003

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

scientific article published on 01 September 1991

Notice of Redundant Publication: “Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease” (Arch Neurol. 2007;64[5]:676-682)—Reply

scholarly article by Joseph Jankovic et al published 1 December 2007 in Archives of Neurology

Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.

artículo científico publicado en 2014

Occupation and parkinsonism in three movement disorders clinics.

artículo científico publicado en 2005

Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease

artículo científico publicado en 2010

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

artículo científico publicado en 2002

Parkin mutations and susceptibility alleles in late-onset Parkinson's disease

article

Progressive supranuclear palsy: neuropathologic and clinical heterogeneity

artículo científico publicado en 1994

Quality of life in Parkinson's disease patients following adjunctive tolcapone therapy: results of an open-label, multicenter, community-based trial.

artículo científico publicado en 2010

Quantifying Improvement Following CNS Transplantation in Hemiparkinsonian Monkeys Using Operant Behavioral Tasks

artículo científico publicado en 1992

Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease

scholarly article by R. L. Watts et al published 3 January 2007 in Neurology

Reliability of a new scale for essential tremor

artículo científico publicado en 2012

Relief of acquired stuttering associated with Parkinson's disease by unilateral left subthalamic brain stimulation

artículo científico publicado en 2009

Replication of association between ELAVL4 and Parkinson disease: the GenePD study

artículo científico publicado en 2008

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families

artículo científico publicado en 2007

Short latency activation of cortex by clinically effective thalamic brain stimulation for tremor

artículo científico publicado en 2012

Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease

artículo científico publicado en 2012

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

artículo científico publicado en 2003

Spatial topographies of unilateral subthalamic nucleus deep brain stimulation efficacy for ipsilateral, contralateral, midline, and total Parkinson disease motor symptoms

artículo científico publicado en 2015

Spheramine for treatment of Parkinson's disease

artículo científico publicado en 2008

Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease

artículo científico publicado en 2003

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

artículo científico publicado en 2007

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

artículo científico publicado en 2008

The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's disease

artículo científico publicado en 2009

The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease

artículo científico publicado en 2016

The effects of deep brain stimulation on sleep in Parkinson's disease.

artículo científico publicado en 2011

The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease.

artículo científico publicado en 2013

The role of dopamine agonists in early Parkinson's disease ⬇️

artículo científico publicado el 1 de julio de 1997

The α-synuclein gene is not a major risk factor in familial Parkinson disease

article

Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease

artículo científico publicado en 2011

Weight changes associated with unilateral STN DBS and advanced PD.

artículo científico publicado en 2009

Lista de obras de Ray L. Watts

A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study

A long-term study of istradefylline in subjects with fluctuating Parkinson's disease

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

Absence of previously reported variants in theSCNA (G88C and G209A),NR4A2 (T291D and T245G) and theDJ-1 (T497C) genes in familial Parkinson's disease from theGenePD study

Activation of subthalamic neurons by contralateral subthalamic deep brain stimulation in Parkinson disease ⬇️

Age at onset in two common neurodegenerative diseases is genetically controlled

An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines

Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists ⬇️

Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

Benefits and Risks of Pharmacological Treatments for Essential Tremor

Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year

Brain N-acetylaspartate is reduced in Parkinson disease with dementia

Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid.

Clozapine is beneficial for psychosis in Parkinson's disease

Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PD.

Complete genomic screen in Parkinson disease: evidence for multiple genes.

Complications of Gamma Knife Surgery for Parkinson Disease

Construction of relational topographies from the quantitative measurements of functional deep brain stimulation using a 'roving window' interpolation algorithm

Corticobasal degeneration

Corticobasal degeneration: neuropathologic and clinical heterogeneity

Depression associated with Parkinson's disease: clinical features and treatment

Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease

Early Experience with Autologous Intrastriatal Adrenal Medulla/Nerve Cografting in Parkinson's Disease

Effect of Stereotaxic Intrastriatal Cografts of Autologous Adrenal Medulla and Peripheral Nerve in Parkinson's Disease: Two-Year Follow-up Study ⬇️

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

Effects of deep brain stimulation frequency on bradykinesia of Parkinson's disease

Electrophysiologic analysis of early Parkinson's disease

Electrophysiologic analysis of early Parkinson's disease

Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study.

Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease

Genome-wide scan for Parkinson's disease: the GenePD Study

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study

High-frequency deep brain stimulation of the putamen improves bradykinesia in Parkinson's disease

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study

Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementia.

Implantation of Spheramine in advanced Parkinson's disease (PD).

Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study

Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease

Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia.

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

Notice of Redundant Publication: “Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease” (Arch Neurol. 2007;64[5]:676-682)—Reply

Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.

Occupation and parkinsonism in three movement disorders clinics.

Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

Parkin mutations and susceptibility alleles in late-onset Parkinson's disease

Progressive supranuclear palsy: neuropathologic and clinical heterogeneity

Quality of life in Parkinson's disease patients following adjunctive tolcapone therapy: results of an open-label, multicenter, community-based trial.

Quantifying Improvement Following CNS Transplantation in Hemiparkinsonian Monkeys Using Operant Behavioral Tasks

Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease

Reliability of a new scale for essential tremor

Relief of acquired stuttering associated with Parkinson's disease by unilateral left subthalamic brain stimulation

Replication of association between ELAVL4 and Parkinson disease: the GenePD study

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families

Short latency activation of cortex by clinically effective thalamic brain stimulation for tremor

Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

Spatial topographies of unilateral subthalamic nucleus deep brain stimulation efficacy for ipsilateral, contralateral, midline, and total Parkinson disease motor symptoms

Spheramine for treatment of Parkinson's disease

Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's disease

The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease

The effects of deep brain stimulation on sleep in Parkinson's disease.

The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease.

The role of dopamine agonists in early Parkinson's disease ⬇️

The α-synuclein gene is not a major risk factor in familial Parkinson disease

Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease